DCF Advisers’s Viridian Therapeutics VRDN Stock Holding History

DCF Advisers’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$867K	Hold
2025 Q1	$836K	Buy
2024 Q4	$570K	Buy
2024 Q3	$330K	Sell
2024 Q2	$231K	Buy
2024 Q1	$254K	Buy
2023 Q4	$207K	Sell
2023 Q3	$207K	Sell
2023 Q2	$452K	Buy